Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frandsen

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Blood|December 4, 2004
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon systemJohn R Ohlfest, Joel L Frandsen, Sabine Fritz, et al.
Pediatric Transplantation|August 21, 2023
Contemporary outcomes of pediatric cardiac transplantation with a positive retrospective crossmatchIrene D Lytrivi, Devin Koehl, Paul Esteso, et al.
International Journal of Cancer|March 3, 2020
Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiotaSilvia De Pietri, Anna C Ingham, Thomas L Frandsen, et al.
Blood|November 5, 2020
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemiaSofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, et al.
Pediatric Blood & Cancer|April 20, 2017
Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolitesLinea Natalie Toksvang, Silvia De Pietri, Stine N Nielsen, et al.
Blood Advances|October 9, 2021
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 studyLine Stensig Lynggaard, Cecilie Utke Rank, Stefan Nygaard Hansen, et al.
Pediatric Blood & Cancer|July 23, 2016
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia casesMette Levinsen, Hanne V Marquart, Line Groth-Pedersen, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Leukemia|July 26, 2016
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocolB O Wolthers, T L Frandsen, J Abrahamsson, et al.
Leukemia|August 19, 2017
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemiaN Toft, H Birgens, J Abrahamsson, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Blood|December 4, 2004
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon systemJohn R Ohlfest, Joel L Frandsen, Sabine Fritz, et al.
Pediatric Transplantation|August 21, 2023
Contemporary outcomes of pediatric cardiac transplantation with a positive retrospective crossmatchIrene D Lytrivi, Devin Koehl, Paul Esteso, et al.
International Journal of Cancer|March 3, 2020
Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiotaSilvia De Pietri, Anna C Ingham, Thomas L Frandsen, et al.
Blood|November 5, 2020
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemiaSofie Gottschalk Højfeldt, Kathrine Grell, Jonas Abrahamsson, et al.
Pediatric Blood & Cancer|April 20, 2017
Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolitesLinea Natalie Toksvang, Silvia De Pietri, Stine N Nielsen, et al.
Blood Advances|October 9, 2021
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 studyLine Stensig Lynggaard, Cecilie Utke Rank, Stefan Nygaard Hansen, et al.
Pediatric Blood & Cancer|July 23, 2016
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia casesMette Levinsen, Hanne V Marquart, Line Groth-Pedersen, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Leukemia|July 26, 2016
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocolB O Wolthers, T L Frandsen, J Abrahamsson, et al.
Leukemia|August 19, 2017
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemiaN Toft, H Birgens, J Abrahamsson, et al.
Pageof 11